Medtronic
MDT
2,023 hedge funds and large institutions have $83.5B invested in Medtronic in 2024 Q2 according to their latest regulatory filings, with 140 funds opening new positions, 823 increasing their positions, 840 reducing their positions, and 162 closing their positions.
32% more call options, than puts
Call options by funds: $652M | Put options by funds: $492M
0% more ownership
Funds ownership: 82.71% → 82.71% (+0%)
2% less repeat investments, than reductions
Existing positions increased: 823 | Existing positions reduced: 840
3% less funds holding
Funds holding: 2,075 → 2,023 (-52)
13% less capital invested
Capital invested by funds: $95.7B → $83.5B (-$12.2B)
14% less first-time investments, than exits
New positions opened: 140 | Existing positions closed: 162
26% less funds holding in top 10
Funds holding in top 10: 31 → 23 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$139M |
| 2 |
Morgan Stanley
New York
|
+$104M |
| 3 |
Millennium Management
New York
|
+$86.7M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$85.4M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$80.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$650M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$401M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$348M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$259M |
| 5 |
JP Morgan Chase
New York
|
-$251M |
MDT Hedge Fund Activity: Q2 2024 in Review
2,023 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2024, worth a combined $83.5B — down 13% from $95.7B a quarter earlier.
Sellers outnumbered buyers: 162 funds closed out of MDT and 140 opened new positions — a net loss of 22 holders — while 840 trimmed existing stakes and 823 added.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $139M. The largest seller was T. Rowe Price Associates, cutting an estimated $650M.
- 2,023 institutional investors held Medtronic (MDT) as of Q2 2024, down from 2,075 in Q1 2024.
- Funds reported $83.5B of Medtronic stock for Q2 2024, down 13% quarter-over-quarter.
- 140 funds opened new Medtronic positions in Q2 2024 and 162 closed out, a net change of -22 holders.
- The largest Medtronic buyer in Q2 2024 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $139M added.
- The largest Medtronic seller in Q2 2024 was T. Rowe Price Associates, an estimated $650M sold.
Based on aggregated 13F filings for Q2 2024.